191 related articles for article (PubMed ID: 19266050)
1. Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.
Sorensen FB; Jensen K; Vaeth M; Hager H; Funder AM; Safwat A; Keller J; Christensen M
Sarcoma; 2008; 2008():874075. PubMed ID: 19266050
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
[TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug resistance membrane transporter (Pgp) and p53 protein in canine mammary tumours.
Koltai Z; Vajdovich P
Acta Vet Hung; 2014 Jun; 62(2):194-204. PubMed ID: 24659714
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.
Gao Y; Liao Y; Shen JK; Feng Y; Choy E; Cote G; Harmon D; Mankin HJ; Hornicek FJ; Duan Z
J Orthop Res; 2016 Sep; 34(9):1606-12. PubMed ID: 26790551
[TBL] [Abstract][Full Text] [Related]
8. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.
Tóth K; Vaughan MM; Slocum HK; Arredondo MA; Takita H; Baker RM; Rustum YM
Am J Pathol; 1994 Feb; 144(2):227-36. PubMed ID: 7508682
[TBL] [Abstract][Full Text] [Related]
9. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response.
Ng IO; Liu CL; Fan ST; Ng M
Am J Clin Pathol; 2000 Mar; 113(3):355-63. PubMed ID: 10705815
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of P-glycoprotein expression in breast cancer.
Linn SC; Giaccone G; van Diest PJ; Blokhuis WM; van der Valk P; van Kalken CK; Kuiper CM; Pinedo HM; Baak JP
Ann Oncol; 1995 Sep; 6(7):679-85. PubMed ID: 8664189
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma.
Kuttesch JF; Parham DM; Luo X; Meyer WH; Bowman L; Shapiro DN; Pappo AS; Crist WM; Beck WT; Houghton PJ
J Clin Oncol; 1996 Mar; 14(3):886-900. PubMed ID: 8622037
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma.
Axiotis CA; Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Am J Pathol; 1991 Apr; 138(4):799-806. PubMed ID: 1707232
[TBL] [Abstract][Full Text] [Related]
13. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
Larkin A; O'Driscoll L; Kennedy S; Purcell R; Moran E; Crown J; Parkinson M; Clynes M
Int J Cancer; 2004 Nov; 112(2):286-94. PubMed ID: 15352042
[TBL] [Abstract][Full Text] [Related]
14. Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma.
Ng IO; Lam KY; Ng M; Kwong DL; Sham JS
Cancer; 1998 Sep; 83(5):851-7. PubMed ID: 9731886
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival.
Wood P; Burgess R; MacGregor A; Yin JA
Br J Haematol; 1994 Jul; 87(3):509-14. PubMed ID: 7993790
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.
Dhaliwal RS; Kitchell BE; Ehrhart E; Valli VE; Dervisis NG
J Am Anim Hosp Assoc; 2013; 49(3):175-84. PubMed ID: 23535752
[TBL] [Abstract][Full Text] [Related]
20. P-170 Glycoprotein (MDR) and p53 Expression in Breast Cancer.
Ciaparrone M; Terribile D; Curigliano G; Marra A; Sgambato A; Boninsegna A; Masetti R; Carbone A; Flamini G; Picciocchi A; Cittadini A
Breast J; 1998 Jul; 4(4):270-6. PubMed ID: 21223447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
